Jennifer Stratton

Title: Innovations of Jennifer Stratton in Antibody Research

Introduction

Jennifer Stratton is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody variants that can effectively cross the blood-brain barrier. Her work has the potential to advance therapeutic options for neurological conditions.

Latest Patents

Jennifer Stratton holds 1 patent for her invention titled "Antibody variants transmigrating the blood-brain barrier and uses thereof." This invention focuses on polypeptides capable of crossing the blood-brain barrier, derived through site-directed mutagenesis of existing antibody fragments. The polypeptides demonstrate enhanced capabilities for blood-brain barrier crossing and improved brain exposure levels both in vitro and in vivo.

Career Highlights

Throughout her career, Jennifer has worked with esteemed organizations such as the National Research Council of Canada and Cephalon, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jennifer has collaborated with notable colleagues, including Danica Stanimirovic and Traian Sulea. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Jennifer Stratton's work in antibody research exemplifies the intersection of innovation and biotechnology. Her contributions are paving the way for new treatments that could significantly improve patient outcomes in neurological health.